Table 1: Demographic data, microbiological findings, and treatment information of 8 patients suffering from a spondylodiscitis and being treated with vancomycin-loaded, cancellous bone grafts.

Patient12345678

Age/gender73/F65/M61/M73/F75/F83/F77/F43/M
Spondylodiscitis localizationL3/4L4/5Th 6/7Th 8/9L3/4L2/3Th12/L1Th10-11
Pathogen organismn.o.i.S. hominisS. epidermidisE. cloacaeMRSAE. colin.o.i.S. aureus
Surgical therapyOne-stage anterior-posterior stabilizationOne-stage anterior-posterior stabilizationTwo-stage anterior-posterior stabilizationOne-stage anterior-posterior stabilizationTwo-stage anterior-posterior stabilizationOne-stage anterior-posterior stabilizationTwo-stage anterior-posterior stabilizationOne-stage anterior-posterior stabilization
Implant usedVLIFT + AIBGsAIBGsVLIFT + AIBGsVLIFT + AIBGsAIBGsAIBGsAIBGsVLIFT + AIBGs
Intravenous antibiotic therapyMeronem + daptomycinLevofloxacinCefuroxime + rifampicinCeftazidime + refobacinRifampicin + daptomycinCefotaximeClindamycinCefuroxime
Oral antibiotic therapyLevofloxacinLevofloxacinLinezolidLevofloxacinLinezolidCiprofloxacineCiprofloxacineCefuroxime
Follow-up [months]132716123612124

M: male; F: female; n.o.i.: no organism isolated; AIBGs: antibiotic-impregnated bone graft; MRSA: methicillin-resistant Staphylococcus aureus.